Baxter Recalls Potassium Chloride Injection

On Wednesday, the U.S. Food and Drug Administration (FDA) announced that Baxter International is recalling one lot of potassium chloride injection (10 mEq per 100 mL).

The recall is due to shipping carton mislabeling. In place of potassium chloride, the cartons may contain gentamicin sulfate injection 80 mg in 100 mL, with product code 2B0862.

The affected lot is # P318220, NDC # 0338-0709-48, product code 2B0826. It was distributed from May 26, 2014, and August 8, 2014 in the United States.

The FDA recommends that healthcare providers check product labeling be before administering.

No adverse events have been reported.

If you have questions, contact Baxter at 1-800-422-9837 or via email at onebaxter@baxter.com.

-- Stephanie Vaccaro 

References:

1. Baxter Initiates U.S. Voluntary Recall of One Lot of Potassium Chloride Injection Due to Shipping Carton Mislabeling [press release]. Baxter International Inc. 2014 Sep 16.

2. Potassium Chloride Injection (Baxter): Recall - Shipping Carton Mislabeling [press release]. www.fda.gov. 2014 Sep 17.